SC
CL icon

Solstein Capital’s Colgate-Palmolive CL Stock Holding History

Solstein Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6K Buy
+253
New +$22.5K 0.01% 294
2025
Q3 		– Sell
-149
Closed -$13.5K – 461
2025
Q2 		$13.5K Buy
+149
New +$13.6K 0.01% 315
2020
Q3 		– Sell
-232
Closed -$17K – 205
2020
Q2 		$17K Hold
232
– – 0.04% 178
2020
Q1 		$15K Hold
232
– – 0.06% 167
2019
Q4 		$16K Buy
+232
New +$15.8K 0.03% 214

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Solstein Capital's CL Position: Q1 2026 in Review

Solstein Capital opened a new position in Colgate-Palmolive (CL) in Q1 2026: 253 shares worth $21.6K. The stake represents 0.01% of the portfolio and ranks #294 among its holdings. This is a return to the name: Solstein Capital previously reported a position in CL as recently as Q2 2025.

Solstein Capital first reported a position in CL in Q4 2019 and has held it in 5 quarters since. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Solstein Capital held 253 shares of Colgate-Palmolive worth $21.6K as of Q1 2026.
  • Colgate-Palmolive was a new Solstein Capital position in Q1 2026.
  • Colgate-Palmolive made up 0.01% of Solstein Capital's portfolio in Q1 2026, its #294 holding.
  • Solstein Capital first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 5 quarters since.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.